Publication: 243

A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG study1
      QxMD      Google Scholar   
Citation:
Am J Clin Oncol vol 31 (6) 573-579
Year:
2008
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
644  
Children:
None
Program:
OGC
Primary Committee:
Experimental
Sec. Committees:
   
Pharmas:
 
Grants:
M01 RR000585, U10 CA052352, U10 CA037417, CA-37404, M01 RR000585-332026, U10 CA060276, CA-52352, CA-35195, M01 RR000585-332075, U10 CA037404, U10 CA035195, CA-35103, CA-25224, CA-60276, U10 CA035101, U10 CA035415, U10 CA063849, CA-35415, CA-37417, CA-35101, U10 CA025224, CA-63849, U10 CA035103  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
NCCTG-N0071
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
1
Keywords:
GM-CSF, melanoma, aerosol, immunotherapy